Objective-Nuclear imaging of active plaques still remains challenging. Advanced atherosclerotic plaques have a strong expression of P-selectin by the endothelium overlying active atherosclerotic plaques, but not on the endothelium overlying inactive fibrous plaques. We proposed a new approach for noninvasive in vivo characterization of P-selectin on active plaques based on 68 Ga-Fucoidan, which is a polysaccharidic ligand of P-selectin with a nanomolar affinity.
S everal criteria are available to evaluate atherosclerotic plaques, such as inflammatory activity, calcified nodules, yellow appearance, luminal stenosis, intraplaque hemorrhage, and structure. [1] [2] [3] [4] At advanced stages of atherosclerosis, plaques most commonly present with luminal stenosis, lipid aggregates, large necrotic cores, intensive macrophages infiltration, and a thin, collagen-poor fibrous cap. Luminal stenosis is the most common indicator of plaque burden in clinical trails. However, plaque rupture is more closely correlated with the extent of inflammation in the plaque. [5] [6] [7] Nuclear imaging techniques such as positron emission tomography (PET) or single-photon emission computed tomography (SPECT) provide novel methods to understand the pathophysiology and propagation of disease. Numerous metabolic or pathophysiological biomarkers associated with plaque vulnerability were used as imaging targets. Among them, 99m Tc-labeled matrix metalloproteinase (MMP) inhibitors were successfully used to assess MMP activation in atherosclerosis noninvasively 8 ; macrophage apoptosis may be detected by using 99m T C -labeled annexin-V 9 ; 18 F-galacto-RGD was used to visualize angiogenesis within the plaque by targeting αvβ3 integrin. 10 Furthermore, the somatostatin receptoravid radiotracer 68 Ga- [1,4,7,10- tetraazacyclododecane-N,N′,N″, N′″-tetraacetic acid]-d-Phe1,Tyr3-octreotate (DOTATATE) detected macrophages in atherosclerotic plaque both in human and animal studies. 11, 12 In clinical and preclinical studies, 18F-fluorodeoxyglucose ( 18 F-FDG) is the most commonly used tracer to assess inflamed plaques by evaluating the glucose metabolism of activated macrophage. 13 P-selectin is an adhesion molecule, which is highly expressed on the surface of active endothelium and platelets. It plays a pivotal role in recruiting leukocytes to the sites of injury. [14] [15] [16] This interaction is mediated by P-selectin glycoprotein ligand 1, expressed by monocytes, neutrophils, and platelets. 17, 18 Most active atherosclerotic lesions remain undetected until plaque rupture and thrombosis occur. A previous study found that inflamed atherosclerotic plaques have a strong expression of P-selectin on the overlying endothelium, but much less in normal arterial endothelium or in endothelium overlying inactive fibrous plaques. 19 Consequently, P-selectin is thought to be an effective biomarker for assessing the bioactivity of active plaques.
Fucoidan is a synthetic sialyl-lewis X mimic, which is the natural ligand of P-selectin and is found on leukocytes. 20, 21 It is mainly derived from brown seaweed with an efficient binding of P-selectin as well. 22 In previous studies, a high specific affinity of fucoidan for P-selectin was confirmed. 22 We developed a novel PET tracer by an efficient introduction of the positron emitter 68 Ga into the Fucoidan moiety. The 68 Ga-Fucoidan obtained this way was used to validate the P-selectin expression in vivo on an established apolipoprotein E-deficient (apoE −/− ) mouse model of atherosclerosis by animal PET. Because lipopolysaccharide is able to upregulate the expression of P-selectin on the endothelial cells, 23, 24 it was used to stimulate an acute inflammatory response and dysfunctional effect in endothelial cells to evaluate the specificity of the radiotracer. MRI can assess plaque stability by evaluating the size of the lipid core, fibrotic caps, and calcifications; 17.6T MRI was also performed as anatomic reference.
Materials and Methods
Materials and Methods are available in the online-only Supplement.
Results

Synthesis of 68
Ga-Fucoidan, In Vitro Stability, and Pharmacokinetics Analysis
For optimization of the radiolabeling conditions, different amounts of Fucoidan (10-250 μg), reaction times (5-45 minutes), and reaction temperatures (22-95°C) were tested. It was found that Fucoidan could be labeled with 68 Ga at 90°C <10 minutes using 100 μg of Fucoidan at pH 3.4. Ga-Fucoidan was obtained in an overall decay-corrected reaction yield of 90±5% and 99% radiochemical purity. The total synthesis time including column purification on a reversed-phase cartridge and quality control were completed after 40 minutes. To determine the stability of 68 Ga-Fucoidan in injection solution (PBS), additional thin layer chromatography and high-performance liquid chromatography controls were performed, at 30 minutes and 1, 2, 3, and 4 hours after pharmacological formulation of 68 Ga-Fucoidan. Radioactivity profiles of both thin layer chromatography and high-performance liquid chromatography identified only 1 radioactive product. The radiochemical purity of the product was still >99%, and thus 68 Ga-Fucoidan showed an excellent in vitro stability in an injection solution (PBS) for further biological investigations (chromatograms are shown in Figure I in the online-only Data Supplement).
To assess the biodistribution of 68 Ga-Fucoidan in mice, all data were corrected for decay and residual activity at the injection site; the tracer uptake was expressed as the percentage of injected dose per gram of tissue after correction for decay ( Figure 1 ). Biodistribution data are expressed as %ID/g: kidney=5.9±1. 4 
Lipopolysaccharide-Enhanced
68
GaFucoidan Cellular Uptakes
Incorporation of 68 Ga-Fucoidan into lipopolysaccharide-treated and nontreated bEnd.3 endothelial cells was determined using a high-energy gamma counter. Compared with noninduced endothelial cells, lipopolysaccharide-induced cells showed ≈2-fold increased uptake of 68 Ga-Fucoidan (Figure 2A ). The radioactivity incorporation in endothelial cells after a 30-minute incubation at 37°C varied ≈35% of the total loaded activity per 10 6 cells (522-546 counts per minute per 1000 cells). We examined the effect on expression of P-selectin proteins in response to the inflammation inducer lipopolysaccharide. An upregulation of P-selectin on lipopolysaccharide-induced bEnd.3 cells was observed in comparison to cells of untreated controls; this was confirmed by Western blot ( Figure 2B ). per day during 3 weeks) into C57BL/6 mice (n=10), and no detectable side effects were observed. Therefore, no significant cytotoxic effects were observed in high doses of Fucoidan.
Cell Viability Assessment
Ex Vivo Detection of P-Selectin Expression on Atherosclerotic Plaques
68
Ga-Fucoidan specifically accumulates in unstable plaques with high-density macrophage infiltration, but much less in fibrous plaques with low-density macrophage presence assessed by autoradiography. Representative autoradiography images are shown in Figure 3 . Plaque morphology and activity were assessed by H&E and DAB histological staining. Immunohistochemical staining of adjacent aorta sections indicated an enhanced P-selectin expression in high-lipid atherosclerotic plaques with high-density macrophage interaction, but weaker expression in fibrotic plaques with lower density of macrophage ( Figure 3 ).
In the assessment of ex vivo accumulation of 68 Ga-Fucoidan of apoE −/− mice, autoradiographic images were evaluated. We studied 267 lesions (152 active lipid-rich plaque segments with highdensity macrophages, 66 inactive fibrous plaque segments with lower-density macrophages, and 49 nonplaque areas with fatty streaks or healthy endothelium), which were selected according to histology. The tracer uptake in active soft plaque areas was higher than in inactive fibrous plaque area (R=1.7±0.3; P<0.05) in each single apoE −/− mouse and also significantly higher than in the nonplaque endothelial segments (R=2.4±0.4; P<0.01). Furthermore, double immunofluorescence staining revealed P-selectin expression on the endothelium overlying soft inflamed plaques as indicated by von Willebrand factor staining and colocalization with macrophages within the active plaque (Figure 4 ).
In Vivo Detection of P-Selectin Expression
Dynamic PET studies (n=10) determined the optimum imaging time. Because of high level of radiotracer in the blood and difficulty in localizing the focal uptake at early time points, PET images were assessed by collection of 6 frames in duration from 50 minutes to >100 minutes. Subsequent work showed that 60 to 70 minutes could be used without significant degradation of the arterial signal. Data from each frame are independently analyzed ( Figure 5 ). For statistics, micro-PET images were obtained at 60 minutes from apoE −/− mice (n=20); regions of interest were assigned to the aortic arch, descending aorta, and abdominal aorta. Representative micro-PET images showed tracer accumulation in the atherosclerotic lesions at coronal view matching the Sudan IV staining ( Figure 5 ). Clear localized focal uptake of 68 Ga-Fucoidan at time points of 60 minutes was detected in all apoE −/− mice with standardized uptake value of plaque=5.1±0.5 (mean), standardized uptake value of muscle=1.0±0.2 (mean), and mean of target to background ratio=5.1±0.8.
The specific accumulation of radiotracer at atherosclerotic plaques was also correlated with histological lipid staining, noninvasively with 17.6T MRI. The representative micro-PET, high-resolution MRI and autoradiography of aorta arch section showed good agreement between uptake of 68 Ga-Fucoidan and plaque vulnerable morphology ( Figure 6 ). No specific vascular uptake was detected at control mice (data not shown). Significant uptake in the myocardium was observed in all apoE −/− mice. Another representative image on a brachiocephalic artery section is given in Figure III in the online-only Data Supplement.
In Vivo and Ex Vivo Blocking Studies
Receptor blockage using sialyl-lewis X, the nature ligand of P-selectin, resulted in a significant decrease of tracer accumulation in aorta sections from apoE −/− mice, which indicated that the accumulation of the radiotracer was especially mediated by cellular P-selectin expression. The signal intensities characterized by target to background ratio were significantly decreasing (P<0.01) from 5.2±0.7 with no inhibition to 2.6±0.4 with inhibition. A strong decrease at plaque was observed after incubation of sialyl-lewis X on atherosclerotic aorta sections. This blocking effect was obvious on the 
Discussion
Despite many efforts and great advances in technologies, the detection of vulnerable plaque at risk of rupture still remains challenging. Noninvasive detection of upregulation of P-selectin on active endothelium could become an effective tool to evaluate the risk of atherosclerosis and thrombosis because of increased P-selectin expression on vulnerable atherosclerotic plaques.
In this study, we described, for the first time to our knowledge, a P-selectin affinity PET tracer, 68 Ga-Fucoidan, as a promising imaging probe to visualize murine atherosclerosis. We established an efficient and rapid synthesis of 68 Ga-Fucoidan, which could be applicable for potential clinical uses. The preparation of 68 Ga-Fucoidan was reproducible in providing 1 stable product, as shown by radio-high-performance liquid chromatography and radio-thin layer chromatography analysis ≤4 hours (equivalent of 3.5×half-lifes of 68 Ga) after preparation. Fucoidans are structurally complex, largely because of their high and polydisperse molecular weight, heterogeneous sugar composition, complex sulfation patterns, and linkages. Therefore, their structural characterization has hitherto challenged analysts and pharmacologists. In the past, the structure and composition of fucoidans have been extensively investigated, and many aspects of their biological activity have been elucidated. 25, 26 Fucoidan used for radiolabeling in our study was derived from Fucus vesiculosus and purchased commercially from Sigma-Aldrich with a purity of >95%. Fucoidan from F vesiculosus has been one of the fucoidans that has been fully characterized in the last decade. [27] [28] [29] Its chemical composition is relatively simpler because it is mainly composed of l-fucose and sulfate residues. On the basis of the results of methylation, fractionation, and on recent gas chromatography-mass spectrometry data, [27] [28] [29] it was suggested that the core region of Fucoidan was primarily a polymer of α-(1→3)-linked L-fucose with sulfate groups substituted at the C-4 position on some of the fucose units; fucose was also attached to this polymer to form branched points, one for every 2 to 3 fucose residues within the chain. Although the main goal of our study was to provide a stable 68 Ga-Fucoidan for imaging P-selectin expression on plaques rather than to characterize its structure, it is assumed that in the stable 68 Ga-Fucoidan complex the TcFucoidan. 27 A further characterization of a chemical structure requires, beside gas chromatography/electrospray ionizationmass spectrometry, a 3-dimensional crystallographic analysis. This is not applicable for radiopharmaceuticals labeled by short half-life PET radionuclides such as 68Ga. A nonradioactive analogue of 68 Ga-Fucoidan (eg, Ga-Fucoidan) is required for further chemical characterizations. 68 Ga-Fucoidan was tested in vitro, in vivo, and ex vivo. 68 Ga-Fucoidan showed high binding efficiency in the cell study. In micro-PET study, high specificity and sensitivity were confirmed by strongly pronounced uptake at aortic atherosclerotic region with high target to background ratio at time point of 60 minutes postinjection.
Recently, Rouzet et al 30 reported on a new SPECT tracer, 99m
Tc-Fucoidan, which was developed to detect P-selectin's upregulation in 2 different animal models of myocardial ischemia reperfusion injury and platelet-rich thrombus. In this study, a good targeting efficiency of Tc and because of the wide availability of SPECT scanners in every nuclear medicine department. However, the current development of PET/MRI scanners and the superiority of an absolute image quantification of PET as compared with SPECT 31 suggests that a Fucoidanbased PET tracer might improve the clinical implications. Furthermore, PET has a superior spatial resolution as compared with SPECT. Overall, 68 Ga-Fucoidan-PET imaging holds sensitive, specific, and economic capability, improving its potential to be used as a clinical agent in the future.
In comparison with other potential radiotracers for assessing plaque vulnerability, 68 Ga-Fucoidan offers more advantages: 18 F-FDG is the most commonly used radiotracer in both clinical and preclinical studies of atherosclerotic plaques. However, the high myocardial and brain uptake of 18 F-FDG remains a severe Ga-Fucoidan. A, In vivo ultrahigh-field MRI of the aortic arch using an ECG-triggered multislice-multi-spin-echo sequence. B, Micro-PET imaging at transverse view suggests specific uptake of 68 Ga-Fucoidan at aortic arch by the plaque. C, Corresponding autoradiographic image of the aortic arch. D, H&E staining of adjacent plaque lesion. Red arrow indicates plaque. Thin cap (bright outer layer) and large lipid core (dark inner part) of the plaque were characterized on MR images and histology, in accordance with high uptake of 68 Ga-Fucoidan confirmed by micro-PET and autoradiography. E, Sudan IV staining of aorta lesion of an apoE −/− mouse fed with Western diet for 40 wk, demonstrating plaque development along aorta. F, 68 Ga-Fucoidan-PET image of aorta lesions from apoE −/− mice with severe plaque with (left) and without (right) preincubation of free sLe X . G, Uptake value at 60 min at atherosclerotic aorta with and without P-selectin inhibition. Data are given as mean±SD; n=6; *P<0.01. drawback, if coronaries or brain vessels need to be assessed. 32 In a previous study using the somatostatin receptor-avid tracer 68 Ga-DOTATATE to image macrophages, the aorta uptake of 68 Ga-DOTATATE likely shows greater specificity to the vascular inflammation related to 18 F-FDG. 12, 32 Because P-selectin expression is closely associated with increased macrophage infiltration into plaques, further correlation between 68 Ga-DOTATATE-PET, 18 F-FDG-PET, and 68 Ga-Fucoidan-PET would be of great interest. In addition, matrix-digesting enzymes (MMPs 2, 3, 9, etc) in the fibrous cap also play a vital role in the rupture of plaque; MMPs secreted by macrophages are specific indicators of the macrophage activity rather than only macrophage density. Noninvasive quantification of MMP activity in atherosclerotic plaques by PET or SPECT has been already published in preclinical models. 8, 33 Massive P-selectin migrates from an inner cell to the endothelial surface in response to the inflammatory mediators. 23 Therefore, P-selectin and MMPs PET have specific superiority to detect the inflammatory activity of plaques. In a previous work, PET imaging of other adhesion molecules for atherosclerosis detection was investigated. Resembling P-selectin, vascular cell adhesion molecule 1 expresses in the early progress of atherosclerosis and is favorably localized on endothelial cells overlying on inflamed plaque as well. Likewise, Nahrendorf et al 34 developed a PET tracer 18 F-4V for characterization of vascular cell adhesion molecule 1 on atherosclerotic apoE −/− mice and wild-type mice with myocardial infarction and heart transplant rejection. In addition, they used PET/MRI to investigate signaling pathways of monocytes and their progenitors after therapy of myocardial infraction in atherosclerotic mice with myocardial infraction. 35 The pharmacological effect of Fucoidan in processing antiinflammation and antithrombotic impact was approved. 36 In our study, the specificity of 68 Ga-Fucoidan was confirmed by in vivo micro-PET imaging with low background signal and in vitro receptor blocking study. The reason we used the standardized uptake value in muscle instead of blood pool to calculate target to background ratio is the inherent limitation of long blood half-life. However, clear uptake at vascular wall was observed at many aortal segments. So far, no reliable method exists to detect early inflammatory atherosclerotic lesions. 37 Within early atherosclerosis-prone regions of the vasculature, active endothelial cells express P-selectin as well. It is thought to be an effective marker to assess the processes in early atherosclerotic endothelial dysfunction. 18, [38] [39] [40] [41] Additionally, the expression of P-selectin is increased in active platelets during vascular thrombus formation, which is subsequent for growth and stabilization of the thrombus by forming large stable platelet-leukocyte complexes. 23, 41 Consequently, because P-selectin plays an important role in cardiovascular inflammation and hemostasis, a validated 68 Ga-Fucoidan-PET imaging holds promising potential in various clinical cardiovascular settings, such as thrombosis, myocardial ischemia, and evaluation for ischemic injury therapies. However, imaging coronary artery atherosclerosis presents special challenges. These arteries are smaller than the PET resolution. In our study, unspecific myocardial accumulation of 68 Ga-Fucoidan was not confirmed, from cardiac endothelium, coronary artery, or blood and requires more symmetrical assessments in coming studies.
Limitations
Because of high inherent sensitivity, PET imaging holds superiority in the detection of diseased lesions as small as atherosclerotic plaques, but lacks structural information. In combination with CT or MRI, it can have a great potential to assess both the activity and the anatomic details of diseases. Therefore, hybrid scanners such as PET/MRI or PET/CT should be used for further preclinical and clinical studies. Additionally, to adequately reflect the real situation, younger apoE −/− mice, which are at an early stage of atherosclerosis, are also significant for the study. Furthermore, in our study, 68 Ga-Fucoidan-PET shows promising capability to recognize active plaques in the apoE −/− mice model. Nevertheless, these plaques are not going to rupture, which can cause thrombosis. Long blood half-life of radiotracer is also an inherent limitation in plaque imaging.
Conclusions
The P-selectin affinity PET tracer, 68 Ga-Fucoidan, according to this preclinical validation study, may hold the potential to discriminate between active and inactive atherosclerotic plaques. However, further studies are necessary to elucidate the role of this new radiotracer.
